Cargando…
Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial
INTRODUCTION: Resistance to initiating insulin therapy is common for people with type 2 diabetes (T2D) using multiple oral agents, resulting in sustained poor glycemic control. We explored a non-pharmacologic option and examined whether adults with T2D and elevated hemoglobin A1c (HbA1c) who were us...
Autores principales: | Price, David A., Deng, Qianqian, Kipnes, Mark, Beck, Stayce E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177263/ https://www.ncbi.nlm.nih.gov/pubmed/34089138 http://dx.doi.org/10.1007/s13300-021-01086-y |
Ejemplares similares
-
Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial
por: Lawson, Margaret L., et al.
Publicado: (2020) -
Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis
por: Ng, Jack K.C., et al.
Publicado: (2023) -
Real-world Accuracy of CGM in Inpatient Critical and Noncritical Care Settings at a Safety-Net Hospital
por: Finn, Erin, et al.
Publicado: (2023) -
Reduced Carbohydrate Diet Influence on Postprandial Glycemia—Results of a Short, CGM-Based, Interventional Study in Adolescents with Type 1 Diabetes
por: Lejk, Agnieszka, et al.
Publicado: (2022) -
Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial
por: Hásková, Aneta, et al.
Publicado: (2020)